Gender, but not CYP7A1 or SLCO1B1 Polymorphism, Affects the Fasting Plasma Concentrations of Bile Acids in Human Beings

Bile Acids and Derivatives, Their Nuclear Receptors FXR, PXR and Ligands: Role in Health and Disease and Their Therapeutic Potential

(2012) Amazia Zimber et al.   Anti-Cancer Agents in Medicinal Chemistry

Profile of Serum Bile Acids in Noncholestatic Volunteers: Gender-Related Differences in Response to Fenofibrate

(2011) J Trottier et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Mechanism-Based Inactivation of CYP2C8 by Gemfibrozil Occurs Rapidly in Humans

(2011) J Honkalammi et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

No significant effect of the SLCO1B1 polymorphism on the pharmacokinetics of ursodeoxycholic acid

(2011) Xiaoqiang Xiang et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Organic Anion Transporting Polypeptide 1B1: a Genetically Polymorphic Transporter of Major Importance for Hepatic Drug Uptake

(2011) M. Niemi et al.   PHARMACOLOGICAL REVIEWS

Gemfibrozil Markedly Increases the Plasma Concentrations of Montelukast: A Previously Unrecognized Role for CYP2C8 in the Metabolism of Montelukast

(2010) T Karonen et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Grapefruit Juice Greatly Reduces the Plasma Concentrations of the OATP2B1 and CYP3A4 Substrate Aliskiren

(2010) T Tapaninen et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Effect of ABCB1 haplotypes on the pharmacokinetics and renin-inhibiting effect of aliskiren

(2010) Tuija Tapaninen et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Rifampicin reduces the plasma concentrations and the renin-inhibiting effect of aliskiren

(2010) Tuija Tapaninen et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

The CYP2C8 inhibitor gemfibrozil does not affect the pharmacokinetics of zafirlukast

(2010) Tiina Karonen et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Itraconazole, a P-Glycoprotein and CYP3A4 Inhibitor, Markedly Raises the Plasma Concentrations and Enhances the Renin-Inhibiting Effect of Aliskiren

(2010) Tuija Tapaninen et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Gender Modifies the Effect of Ursodeoxycholic Acid in a Randomized Controlled Trial in Colorectal Adenoma Patients

(2009) P. A. Thompson et al.   Cancer Prevention Research

Comprehensive Whole-Genome and Candidate Gene Analysis for Response to Statin Therapy in the Treating to New Targets (TNT) Cohort

(2009) John F. Thompson et al.   Circulation-Cardiovascular Genetics

High performance liquid chromatography–tandem mass spectrometry for the determination of bile acid concentrations in human plasma

(2009) Xiaoqiang Xiang et al.   JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES

Effect of SLCO1B1 polymorphism on the plasma concentrations of bile acids and bile acid synthesis marker in humans

(2009) Xiaoqiang Xiang et al.   Pharmacogenetics and Genomics

CYP7A1promoter polymorphism −203A>C affects bile salt synthesis rate in patients after ileal resection

(2008) Martin Leníček et al.   JOURNAL OF LIPID RESEARCH

Fifty years of advances in bile acid synthesis and metabolism

(2008) David W. Russell   JOURNAL OF LIPID RESEARCH

Polymorphism of the hepatic influx transporter organic anion transporting polypeptide 1B1 is associated with increased cholesterol synthesis rate

(2008) Marja K. Pasanen et al.   Pharmacogenetics and Genomics